New guidelines issued by the American Society for Radiation Oncology (ASTRO) optimize the delivery of radiation therapy for pancreatic cancer patients. Published in August 2026, the updated clinical recommendations refine … Read More
As medical science enters a new era in oncology, cutting-edge therapies like Chimeric Antigen Receptor (CAR) T-cell therapy are moving beyond traditional blood cancers. Recent clinical updates highlight pioneering trials … Read More
Surviving cervical or ovarian cancer brings complex questions about future family planning, including whether lactation remains biologically possible after pelvic oncology treatments. Experts explain that while radical surgeries, chemotherapy, and … Read More
A newly developed portable blood testing device allows for real-time remote health monitoring, bridging the gap between patients at home and clinical laboratories. Developed to streamline point-of-care diagnostics, the technology … Read More
Recent scientific mapping has revealed the complex protective cell networks that shelter dormant breast tumor cells, shedding new light on how cancer persists in the body. Published in medical journals, … Read More
As Merck’s Keytruda (pembrolizumab) approaches its patent cliff, the oncology sector is pivoting toward a new standard of care: the strategic pairing of Antibody-Drug Conjugates (ADCs) with next-generation immunotherapies. This … Read More
Researchers have developed a six-gene molecular signature that predicts colorectal cancer (CRC) recurrence in patients following liver metastases resection. By analyzing gene expression patterns, this diagnostic tool identifies high-risk patients … Read More
A study published this week in Science Translational Medicine reports that engineered CAR T cells effectively target bladder cancer in murine models, marking a potential breakthrough in immunotherapy. The research, … Read More
Researchers have identified the protein LRRC4C as a critical driver of chemotherapy resistance in colorectal cancer patients. By isolating this protein’s role in cellular signaling, scientists have uncovered a potential … Read More
In this week’s landmark announcement, a novel experimental pill—ADXS11-001, a Listeria monocytogenes-based immunotherapy—has shown unprecedented efficacy in Phase II trials for metastatic pancreatic ductal adenocarcinoma (PDAC), the deadliest form of … Read More
